Birmingham to lead ground-breaking research into patient experience of cell therapies

Birmingham health researchers, with industry partners including health technology companies Dignio and Datatrial, have been awarded £1.1 million by UK Research & Innovation (UKRI)’s Innovate UK, to investigate patients’ experience of cell and gene therapies. The funding has been provided as part of the Industrial Strategy Challenge Fund’s Medicines Manufacturing programme. Cell and gene therapies … Continue reading “Birmingham to lead ground-breaking research into patient experience of cell therapies”

Birmingham to lead brain cancer study in memory of Tessa Jowell

Significant funding of up to £2.8m from The Brain Tumour Charity has been awarded to a Birmingham researcher for a major study named in memory of the late Baroness Jowell. The Tessa Jowell BRAIN-MATRIX trial is being co-ordinated by Professor Colin Watts (pictured) of the Institute of Cancer and Genomic Sciences, part of the University of … Continue reading “Birmingham to lead brain cancer study in memory of Tessa Jowell”

Birmingham School of Dentistry in ground-breaking £6.1 million project to develop robot-assisted surgery

BHP founder member the University of Birmingham will be part of a £6.1 million research project aimed at finding new ways to use ultrasonic tools for complex robot-assisted surgery. The Engineering and Physical Sciences Research Council (EPSRC) has granted the funding for the ‘Surgery enabled by ultrasonics’ project which will be led by the University … Continue reading “Birmingham School of Dentistry in ground-breaking £6.1 million project to develop robot-assisted surgery”

New diabetes drug to be trialled in Birmingham

Researchers from the Diabetes Research Unit and the Clinical Research Facility at the Queen Elizabeth Hospital, Birmingham are currently recruiting patients with type 1 diabetes to a trial for a new drug which could change the future of treatment for the condition. The Birmingham trial will be led by Dr Parth Narendran, together with research … Continue reading “New diabetes drug to be trialled in Birmingham”

New partner announced as part of lung cancer research

Mirati Therapeutics, Inc. has been announced as the latest partner of Cancer Research UK’s Stratified Medicine Programme which is being carried out in collaboration with the University of Birmingham Cancer Research Clinical Trials Unit. The partnership will make Mirati’s experimental drug, sitravatinib, available for inclusion in the programme through the National Lung Matrix Trial – … Continue reading “New partner announced as part of lung cancer research”